Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Surgical Oncology

This article is part of the Research TopicArtificial Intelligence in Clinical Oncology: Enhancements in Tumor ManagementView all 10 articles

Machine Lear ning and Shapley Additive Explanations to Predict Metastasis of Lymph Nodes Posterior to the Recurrent Laryngeal Nerve in cN0 Papillar y Thyr oid Car cinoma

Provisionally accepted
Jing  ZhouJing Zhou1,2Ben  LiBen Li1Tao  SunTao Sun1Daxue  LiDaxue Li1Chun  HuangChun Huang2Han  GaoHan Gao1Jiahui  RenJiahui Ren1Yuchen  ZhuangYuchen Zhuang1Song  XueSong Xue3Qian  XiaoQian Xiao2林  淳林 淳4Xinliang  SuXinliang Su2*
  • 1Chongqing Health Center for Women and Children, Chongqing, China
  • 2The First Affilated Hospital of Chongqing Medical University, Chongqing, China
  • 3University of Electronic Science and Technology of China, Chengdu, China
  • 4Guangyuan Central Hospital, Guangyuan, China

The final, formatted version of the article will be published soon.

Objective: Prophylactic dissection of lymph nodes posterior to the recurrent laryngeal nerve (LN-prRLN) in clinically node-negative (cN0) papillary thyroid carcinoma (PTC) remains controversial due to the inability to preoperatively assess LN-prRLN metastasis. Materials and methods: This study aims to construct and validate an interpretable predictive model for LN-prRLN metastasis in cN0 PTC using machine learning (ML) method. Data were collected from hospital A and divided into training and testing sets (7:3). Additional data from the hospital B were used as validation set. Nine ML models, including XGBoost, were developed. Predictive performance was evaluated using ROC curves, decision curve analysis (DCA), calibration curves, and precision-recall curves. The best model was compared to a traditional logistic regression-based nomogram using learning curves and the method of Probability-based Ranking Model Approach (PMRA). SHapley Additive exPlanations (SHAP) were used to interpret the top ten predictive features and create a web-based calculator. Results: A total of 2033 patients were included. XGBoost outperformed other models with AUCs of 0.859, and 0.885 for the testing, and validation sets, respectively, compared to the nomogram (0.814, 0.836). SHAP-based visualizations identified the top ten predictive features: ipsilateral paratracheal lymph node metastasis rate, number of total central lymph node metastases, total central lymph node metastasis rate, number of ipsilateral paratracheal lymph node metastases, pretracheal lymph node metastasis rate, ipsilateral paratracheal lymph node metastasis, unclear tumor border, size, and age ≤39 years. These features were used to develop a web-based calculator. Conclusion: ML is a reliable tool for predicting LN-prRLN metastasis in cN0 PTC patients. The SHAP method provides insights into the XGBoost model, and the resultant web-based calculator is a clinically useful tool to assist in the surgical planning for LN-prRLN dissection.

Keywords: cN0: clinically negative neck lymph nodes, PTC: papillary thyroidcarcinoma, LN-prRLN: lymph nodes posterior to the recurrent laryngeal nerve, XGBoost: Extreme Gradient Boosting, SHAP: shapley additive explanations

Received: 25 Jul 2025; Accepted: 17 Nov 2025.

Copyright: © 2025 Zhou, Li, Sun, Li, Huang, Gao, Ren, Zhuang, Xue, Xiao, 淳 and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xinliang Su, 201604@hospital.cqmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.